Sử dụng lâm sàng thực tế của các chelated gadolinium cho các ứng dụng không phải MRI

Oksendal AN,Hals PA (1993) Biodistribution and toxicity of MR imaging contrast media. J Magn Reson Imaging 3:157–165 Harpur ES, Worah D, Hals PA et al (1993) Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Invest Radiol 28 [Suppl 1]:S28–S43 Thomsen HS, Almen T, Morcos SK (2002) Gadolinium-containing contrast media for radiographic examinations: a position paper. Eur Radiol 12:2600–2605 Tweedle MF, Eaton SM, Eckelman WC et al (1988) Comparative chemical structure and pharmacokinetics of MRI contrast agents. Invest Radiol 23 [Suppl 1]:S236–S239 Tweedle MF (1992) Physicochemical properties of gadoteridol and other magnetic resonance contrast agents. Invest Radiol 27 [Suppl. 1]:S2–S6 Nyman U, Elmstahl B, Leander P et al (2002) Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with azotemia? Radiology 223:311–318; discussion 328–329 Janon EA (1989) Gadolinium-DTPA: a radiographic contrast agent. Am J Roentgenol 152:1348 Albrecht T, Dawson P (2000) Gadolinium-DTPA as X-Ray contrast medium in clinical studies. Br J Radiol 73:878–882 Bedair el Said M, El Din Abbas H, Amin M et al (2002) Gadolinium-DTPA: a contrast agent for conventional X-ray and CT examinations; when, why and how? J Med Res Institute 23:1–13 Engelbrecht V, Koch JA, Rassek M (1996) Gadodiamide and gadolinium-DTPA as intravenous media in computed tomography. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 165:24–28 Luboldt W, De SM, von SA et al (1997) Attenuation characteristics and application of gadolinium-DTPA in fast helical computed tomography. Invest Radiol 32:690–695 Quinn AD, O’Hare NJ, Wallis FJ et al (1994) Gd-DTPA: an alternative contrast medium for CT. J Comput Assist Tomogr 18:634–636 Bloem JL,Wondergem J (1989) Gd-DTPA as a contrast agent in CT. Radiology 171:578–579 Chryssidis S, Davies RP,Tie ML (2002) Gadolinium-enhanced computed tomographic aortography. Australas Radiol 46:97–100 Budoff MJ, Lu B,Mao S (2002) Gadolinium-enhanced three-dimensional electron beam coronary angiography. J Comput Assist Tomogr 26:879 Pena CS, Kaufman JA, Geller SC et al (1999) Gadopentetate dimeglumine: a possible alternative contrast agent for CT angiography of the aorta. J Comput Assist Tomogr 23:23–24 Gupta AK, Alberico RA, Litwin A et al (2002) Gadopentetate dimeglumine is potentially an alternative contrast agent for three-dimensional computed tomography angiography with multidetector-row helical scanning. J Comput Assist Tomogr 26:869–874 Kawano T, Ishijima H, Nakajima T et al (1999) Gd-DTPA: a possible alternative contrast agent for use in CT during intraarterial administration. J Comput Assist Tomogr 23:939–940 Kinno Y, Odagiri K, Andoh K et al (1993) Gadopentetate dimeglumine as an alternative contrast material for use in angiography. Am J Roentgenol 160:1293–1294 Amar AP, Larsen DW,Teitelbaum GP (2001) Percutaneous carotid angioplasty and stenting with the use of gadolinium in lieu of iodinated contrast medium: technical case report and review of the literature. Neurosurgery 49:1262–1265; discussion 1265–1266 Hammer FD, Goffette PP, Malaise J et al (1999) Gadolinium dimeglumine: an alternative contrast agent for digital subtraction angiography. Eur Radiol 9:128–136 Schild HH, Weber W, Boeck E et al (1994) Gadolinium-DTPA (Magnevist) as contrast medium for arterial DSA. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 160:218–221 Spinosa DJ, Matsumoto AH, Angle JF et al (1998) Use of gadopentetate dimeglumine as a contrast agent for percutaneous transluminal renal angioplasty and stent placement. Kidney Int 53:503–507 Spinosa DJ, Angle JF, Hagspiel KD et al (1998) Co2 and gadopentetate dimeglumine as alternative contrast agents for malfunctioning dialysis grafts and fistulas. Kidney Int 54:945–950 Spinosa DJ, Angle JF, Hartwell GD et al (2002) Gadolinium-based contrast agents in angiography and interventional radiology. Radiol Clin North Am 40:693–710 Spinosa DJ, Kaufmann JA,Hartwell GD (2002) Gadolinium chelates in angiography and interventional radiology: a useful alternative to iodinated contrast media for angiography. Radiology 223:319–325; discussion 326–327 Wagner HJ, Kalinowski M, Klose KJ et al (2001) The use of gadolinium chelates for X-ray digital subtraction angiography. Invest Radiol 36:257–265 Dinkel HP, Hoppe H, Baumgartner I et al (2002) Low-osmolar gadodiamide as alternative contrast agent for diagnostic angiography and angiographic interventions in patients with renal insufficiency. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 174:56–61 Kaufman JA, Geller SC, Bazari H et al (1999) Gadolinium-based contrast agents as an alternative at vena cavography in patients with renal insufficiency—early experience. Radiology 212:280–284 Schenker MP, Solomon JA,Roberts DA (2001) Gadolinium arteriography complicated by acute pancreatitis and acute renal failure. J Vasc Interv Radiol 12:393 Spinosa DJ, Matsumoto AH, Angle JF et al (1998) Gadolinium-based contrast and carbon dioxide angiography to evaluate renal transplants for vascular causes of renal insufficiency and accelerated hypertension. J Vasc Interv Radiol 9:909–916 Spinosa DJ, Matsumoto AH, Angle JF et al (1999) Renal insufficiency: usefulness of gadodiamide-enhanced renal angiography to supplement CO2-enhanced renal angiography for diagnosis and percutaneous Treatment. Radiology 210:663–672 Spinosa DJ, Matsumoto AH, Hagspiel KD et al (1999) Gadolinium-based contrast agents in angiography and interventional radiology. Am J Roentgenol 173:1403–1409 Spinosa DJ, Angle JF, Hagspiel KD et al (2000) Lower extremity arteriography with use of iodinated contrast material or gadodiamide to supplement CO2 angiography in patients with renal insufficiency. J Vasc Interv Radiol 11:35–43 Kaltenborn H, Schadmand S, Beck T et al (1995) Gadolinium-DTPA (Magnevist) as contrast medium for galactography. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr 163:457–459 Vehmas T,Markkola AT (1998) Gd-DTPA as an alternative contrast agent in conventional and interventional radiology. Acta Radiol 39:223–226 Wenzel R,Leppien A (2000) Gadolinium-myelocisternography for cerebrospinal fluid rhinorrhoea. Neuroradiology 42:874–880 Vehmas T,Tervahartiala P (1996) Gd-DTPA in male urethrography. A case report. Acta Radiol 37:804–805 Spinosa DJ, Pao DG, Matsumoto AH et al (2000) Carbon dioxide and gadodiamide as the contrast agents for diagnosis and embolization of a post-biopsy arteriovenous fistula in a renal allograft. Clin Radiol 55:801–803 Spinosa DJ, Hagspiel KD, Angle JF et al (2000) Gadolinium-based contrast agents in angiography and interventional radiology: uses and techniques. J Vasc Interv Radiol 11:985–990 Spinosa DJ, Angle JF, Hagspiel KD et al (2000) Interventional uroradiologic procedures performed using gadodiamide as an alternative to iodinated contrast material. Cardiovasc Intervent Radiol 23:72–75 Niendorf HP, Haustein J, Cornelius I et al (1991) Safety of gadolinium-DTPA: extended clinical experience. Magn Reson Med 22:222–228; discussion 229–232 Shellock FG, Kanal E (1999) Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 10:477–484 Thomsen HS (1997) Frequency of acute adverse events to a non-ionic low-osmolar contrast medium: the effect of verbal interview. Pharmacol Toxicol 80:108–110 Salonen OL (1990) Case of anaphylaxis and four cases of allergic reaction following Gd-DTPA administration. J Comput Assist Tomogr 14:912–913 Arat A, Cekirge HS,Saatci I (2000) Gadodiamide as an alternative contrast medium in cerebral angiography in a patient with sensitivity to iodinated contrast medium. Neuroradiology 42:34–37; discussion 37–39 Erly WK, Zaetta J, Borders GT et al (2000) Gadopentetate dimeglumine as a contrast agent in common carotid arteriography. Am J Neuroradiol 21:964–967 Kaufman JA, Hu S, Geller SC et al (1999) Selective angiography of the common carotid artery with gadopentetate dimeglumine in a patient with renal insufficiency. Am J Roentgenol 172:1613–1614 Nussbaum ES, Casey SO, Sebring LA et al (2000) Use of gadolinium as an intraarterial contrast agent in digital subtraction angiography of the cervical carotid arteries and intracranial circulation. Technical note. J Neurosurg 92:881–883 Prince MR, Arnoldus C,Frisoli JK (1996) Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imaging 6:162–166 Arsenault TM, King BF, Marsh JWJ et al (1996) Systemic gadolinium toxicity in patients with renal insufficiency and renal failure: retrospective analysis of an initial experience. Mayo Clin Proc 71:1150–1154 Matchett WJ, McFarland DR, Russell DK et al (1996) Azotemia: gadopentetate dimeglumine as contrast agent at digital subtraction angiography. Radiology 201:569–571 Rieger J, Sitter T, Toepfer M et al (2002) Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function. Nephrol Dial Transplant 17:824–828 Hammer FD, Malaise J, Goffette PP et al (2000) Gadolinium dimeglumine: an alternative contrast agent for digital subtraction angiography in patients with renal failure. Transplant Proc 32:432–433 Hatrick AG, Jarosz JM, Irvine AT (1997) Gadopentate dimeglumine as an alternative contrast agent for use in interventional procedures. Clin Radiol 52:948–952 Kaufman JA, Geller SC, Waltman AC (1996) Renal insufficiency: gadopentetate dimeglumine as a radiographic contrast agent during peripheral vascular interventional procedures. Radiology 198:579–581